Prof. A.Žvirblienė does not believe in the rapid appearance of the COVID-19 vaccine: if we have it next fall, it will be very good



[ad_1]

There really won’t be until the New

Every day, the growing number of COVID-19 infections is a cause for concern in society, and at least some of them hope to follow the news about the research of a vaccine against this infection. However, A.Žvirblienė is convinced that those who believe that we will have the vaccine in a few weeks or before the New Year should not be fooled.

“It’s hard to say when we’ll have it, it will depend on the success of the phase III clinical trials that have been launched for some candidate vaccines and haven’t even started for some. So if those trials are successful, that vaccine will be registered, if people get vaccinated; if those three questions are answered yes, then in a very optimistic case, we can have the vaccine for the next fall season. It would be just amazing, because it would mean that now we have to put up with that difficult season somehow, and that’s it. we will have protection for the next fall season, “said the professor at the conference” Confrontation with Covid-19: have we gotten stronger? “

If the tests are successful, the vaccine will be registered, if people get vaccinated, then in a very optimistic case, we may have the vaccine for the next fall season.

He also talked about another important thing: that it can happen that we do not have those vaccines, because so far there are many questions. Especially since the vaccine cannot be registered in the European Union (and the Lithuanian people would be vaccinated with it) in the same way that Russia has, the vaccine will have to pass all safety and efficacy tests and only then will it be registered.

Lack of information

A volunteer who participated in clinical trials of a coronavirus vaccine being developed by the University of Oxford was reported to have died in Brazil on Wednesday. The vaccine is being developed with British pharmaceutical giant AstraZeneca. However, A.Žvirblienė stated that he could not comment on the situation, as no official information was provided.

“This was also the case in the first case where the AstraZeneca study was suspended for a week, as was the case with the Johnson & Johnson vaccine, which is still suspended in the third phase. Now we learn from the media that there was a death. And there’s a comment entirely from indirect sources that that death was in the placebo group. This may be because people do not know what they have been vaccinated for, whether it is a placebo or a real vaccine, and studies are being done in countries where the virus is highly prevalent.

123RF.com nuotr./Vakcina

123RF.com nuotr./Vakcina

There, as far as I know from indirect sources, was a young doctor working with COVID-19 patients who died from complications of COVID-19. This could confirm that it really was a placebo group, that the person expected to be protected and perhaps not so much, that is why we have such a situation ”, said the professor.

Not be like in northern Italy

The fact that we have 424 new COVID-19 cases approved on Thursday is really concerning for doctors. According to A.Žvirblienė, if we continue to live as we live today, it will double every two weeks or even ten days.

“When I say that, I get, and even today, I get threats on the phone to stop talking nonsense that scares people, but it’s just a close-up and a reluctance to look the truth in the eye. If we look at a country like the Czech Republic, where there is now ten times the difference with Lithuania and they also missed that moment. When the curve kept going up and there was also optimism that everything will work out here ”, the scientist is convinced, believing that recommendations alone no longer work for people.

If this continues, the virus will spread from the hotspots and we will have a population spread, as has been the case in northern Italy and the United States, where it remains. I really wouldn’t want that to happen in Lithuania.

Society, like psychologists, is said to be threatened by danger because it is human nature, so without strict instructions, voluntary restrictions are not desired and the virus continues to spread rapidly.

“I really like the way people think optimistically, but there are different things when there are 30 cases a day and when there are 400. If that continues, the virus will spread from the hotspots and we will have a spread in the population, as it was. the case of northern Italy and the United States. . I really wouldn’t want that to happen in Lithuania. When you tell me what the reality is, you are called to spread black pessimism, ”said A.Žvirblienė.

The descent can be painful

The political background is also an obstacle here: the professor is convinced that if such a transition period, when quick and strict solutions are needed, came after the elections, it would definitely be better, because now people stay to save themselves.

Photo by Lukas Balandis / 15min / Aurelija Žvirblienė

Photo by Lukas Balandis / 15min / Aurelija Žvirblienė

“If we consider the increase in these numbers as climbing, as much as we climb a mountain, as long as we stop we will have to go backwards. If we look at the numbers now and feel intimidated by those 400, then if we stop today, we will slowly start to decline from 400 cases. But if we stop at only 3 thousand, then that decrease will be really painful ”, is convinced A. Žvirblienė.

If we stop at just 3,000, that decline will be really painful.

It’s hard to expect some of the public’s conscience, says the professor, noting that she recently visited Nemenčinė, where a serological test was performed on people who had COVID-19: “There were paradoxical cases. Here the man got infected, he lay in resuscitation, he was barely rescued, but he says: no, this virus does not exist and it has infected his entire family. That is the reality, how can you expect people who think like that to wear masks, keep their distance and be careful? “

However, a serological test, the results of which the professor promises to present a little later, showed that even half a year after the outbreak in Nemenčinė, most people still have antibodies. This indicates that such immunity develops in COVID-19.



[ad_2]